Revaluing donor and recipient bodies in the globalised blood economy: Transitions in public policy on blood safety in the United Kingdom

Health (United Kingdom)

Volumn 18, Issue 1, 2014, Pages 79-94

  Busby, Helen ^a   Kent, Julie ^b   Farrell, Anne Maree ^c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

Author keywords

'tissue economies'; biovalue; blood; donors; patients; risk

Indexed keywords

'TISSUE ECONOMIES'; ARTICLE; BIOVALUE; BLOOD; BLOOD DONOR; BLOOD SAFETY; DISEASE TRANSMISSION; DONORS; ECONOMICS; HEALTH CARE ORGANIZATION; HUMAN; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT; POLICY; RISK; SAFETY; STANDARD; UNITED KINGDOM; VIRUS INFECTION;

'TISSUE ECONOMIES'; BIOVALUE; BLOOD; DONORS; PATIENTS; RISK;

BLOOD DONORS; BLOOD SAFETY; ECONOMICS; GREAT BRITAIN; HEALTH CARE RATIONING; HUMANS; PUBLIC POLICY; SAFETY MANAGEMENT; VIRUS DISEASES;

EID: 84890872034     PISSN: 13634593     EISSN: 14617196     Source Type: Journal    
DOI: 10.1177/1363459313476966     Document Type: Article

References (58)

1. Adams V,Erwin K,Phuoc V.Public health works: Blood donation in urban China.Social Science & Medicine. 2009;68:410-418.
2. The Social Life of Things: Commodities in Cultural Perspective. Appadurai A, ed. Cambridge: Cambridge University Press; 1986:.
3. Archer - the Right Honourable Lord, JonesNWillettsJ (2009) Independent public inquiry report on NHS supplied contaminated blood and blood products. Available at: http://www.archercbbp.com.
4. Australian Government (2006) Review of Australia's plasma fractionation arrangements. Available at: http://www.donateblood.com.au/files/pdfs/Review%20of%20Australia%27s%20plasma%20fractionation%20arrangements%20Dec06.pdf.
5. AyméSHivertV (eds) (2011) Report on rare disease research, its determinants in Europe and the way forward. INSERM Report for the Orphanet R&D Platform. Available at: http://asso.orpha.net/RDPlatform/upload/file/RDPlatform_final_report.pdf.
6. BennettPDobraS (2009) Mapping out the consequences of screening blood donations for PrPSc. London: Department of Health. Available at: http://www.dh.gov.uk/dr_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_094803.pdf.
7. Berner B.The making of a risk object: AIDS, gay citizenship and the meaning of blood donation in Sweden in the early 1980s.Sociology of Health & Illness. 2011;33 (3): 384-398.
8. Busby H.Trust, nostalgia and narrative accounts of blood banking in England in the twenty first century.Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine. 2010;14 (4): 364-382.
9. Committee on the Safety of Blood, Tissues and Organs (2012a) Importation of fresh frozen plasma: Effectiveness and cost-effectiveness. Available at: https://www.wp.dh.gov.uk/transparency/files/2012/04/120309IMPORTATION-OF-FRESH-FROZEN-PLASMA-v1.1-redaction-amended-June-2012.pdf (accessed 2 October 2012).
10. Committee on the Safety of Blood, Tissues and Organs (2012b) Minutes of the sixteenth meeting. Available at: https://www.wp.dh.gov.uk/transparency/files/2012/04/SaBTO-16-draft-minutes-final-for-pubn-redaction-amended-June2012.pdf (accessed 9 March 2012).
11. Body & Society. Copeman J, ed. 2009:1-28.
12. CSL Limited (2009) Our corporate responsibility 2009. Available at: http://www.csl.com.au/docs/651/1009/CSL_CSR_2009.pdf.
13. European Blood Alliance (2009) Position paper on competition in the EU blood component market. Available at: http://ebaweb.files.wordpress.com/2012/08/eba-position-paper-competition-in-european-blood-component-market-final.pdf.
14. European Commission (2011) 2nd Report on Voluntary and Unpaid Donation of Blood and Blood Components. Brussels: European Commission.
15. Farrell AM.Is the gift still good? Examining the politics and regulation of blood safety in the European Union.Medical Law Review. 2006;14 (2): 155-179.
16. Farrell AM.The politics of risk and EU governance of human material.Maastricht Journal of European and Comparative Law. 2009;16 (1): 41-64.
17. Farrell AMThe Politics of Blood: Ethics, Innovation and the Regulation of Risk. Cambridge: Cambridge University Press; 2012:.
18. Farrugia A.Plasma protein therapies: Current and future perspectives.Best Practice & Research. Clinical Haematology. 2006;19 (1): 243-258.
19. Farrugia A.Globalisation and blood safety.Blood Reviews. 2009;23 (3): 123-128.
20. Farrugia A,Penrod J,Bult JM.Payment, compensation and replacement - The ethics and motivation of blood and plasma donation.Vox Sanguinis. 2010;99 (3): 202-211.
21. Blood Feuds: AIDS, Blood, and the Politics of Medical Disaster. Feldman RBayer A, ed. Oxford: Oxford University Press; 1999:.
22. Franklin M.UK blood transfusion and variant CJD - Stating the problem.The Bulletin of the Royal College of Pathologists. 2004;127:19-21.
23. Giangrande PLF.The history of blood transfusion.British Journal of Haematology. 2000;110 (4): 758-767.
24. Grenfell P,Nutland W,Mcmanus S, et al.Views and experiences of men who have sex with men on the ban on blood donation: A cross sectional survey with qualitative interviews.British Medical Journal. 2011;343:d5604.
25. Healy KLast Best Gifts: Altruism and the Market for Human Blood and Organs. Chicago, IL: University of Chicago Press; 2006:.
26. Hoeyer K.Tradable body parts? How bone and recycled prosthetic devices acquire a price without forming a market.BioSocieties. 2009;4 (2-3): 239-256.
27. House of Lords (2002) Debate 18 December 2002 Vol. 642 cc WA120. Available at: http://www.publications.parliament.uk/pa/ld200203/ldhansrd/vo021218/text/21218w05.htm.
28. Hurley R.Bad blood: Gay men and blood donation.British Medical Journal. 2009;338:b779.
29. Hurley R.UK lifts lifetime ban on gay men giving blood.British Medical Journal. 2011;343:d5765.
30. ISBT (2006) A code of ethics for blood donation and transfusion. International Society for Blood Transfusion. Available at: http://www.isbtweb.org/fileadmin/user_upload/ISBT_Code_of_Ethics/Code_of_ethics_new_logo_-_feb_2011.pdf.
31. Jersild C,Hafner VInternational Encyclopedia of Public Health. Murray CHeggenhougen KQuah S, ed. Amsterdam: Academic Press; 2008:325-329.
32. Kent J.The fetal tissue economy: From the abortion clinic to the stem cell laboratory.Social Science & Medicine. 2008;67 (11): 1747-1756.
33. Knowles S and Cohen H, on Behalf of the Serious Hazards of Transfusion (SHOT) Steering Group (2011) The 2010 annual SHOT report, July 2011. Manchester: SHOT UK Haemovigilance Scheme.
34. Lefrere J,Hewitt P.From mad cows to sensible blood transfusion: The risk of prion transmission by labile blood components in the United Kingdom and in France.Transfusion. 2009;49 (4): 797-812.
35. Handbook of Transfusion Medicine. McClelland D, ed. London: TSO (The Stationery Office); 2007:.
36. National Health Service Blood and Transplant (NHSBT) (2011) NHSBT Strategic Plan 2011-2014, April 2011. Watford: NHSBT.
37. O'Mahony B,Turner A.The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products.Vox Sanguinis. 2010;98:447-450.
38. Oxford English Dictionary (2011) Oxford Dictionaries online. Available at: http://oxforddictionaries.com/definition/blood (accessed 5 October 2011).
39. Palsson G.Biosocial relations of production.Comparative Studies in Society and History. 2009;51 (2): 288-313.
40. Parry S.Reconstructing embryos in stem cell research: Exploring the meaning of embryos for people involved in fertility treatments.Social Science & Medicine. 2006;62 (10): 2349-2359.
41. Pfeffer N,Laws S.'It's only a blood test': What people know and think about venepuncture and blood.Social Science & Medicine. 2006;62 (12): 3011-3023.
42. Plasma Protein Therapeutics Association (2011) Breaking down roadblocks to patient access. The Source, 14-15. Available at: http://www.pptaglobal.org/UserFiles/file/TheSource/2011/fall/201109_14_BREAKING_DOWN_ROADBLOCKS_TO_PATIENT_ACCESS.pdf.
43. Rabinow PFrench DNA: Trouble in Purgatory. Chicago, IL: University of Chicago Press; 1999:.
44. Rose NThe Politics of Life Itself: Biomedicine, Power and Subjectivity in the Twenty-First Century. Princeton, NJ: Princeton University Press; 2007:.
45. Shaw R.Thanking and reciprocating under the New Zealand organ donation system.Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine. 2011;16:298-313.
46. Starr DBlood: An Epic History of Medicine and Commerce. London: Warner Books; 1998:.
47. Svendsen MN,Koch L.Unpacking the 'spare embryo': Facilitating stem cell research in a moral landscape.Social Studies of Science. 2008;38 (1): 93-110.
48. Titmuss RThe Gift Relationship: From Human Blood to Social Policy. London: Allen & Unwin; 1970:.
49. Valentine K.Citizenship, identity, blood donation.Body & Society. 2005;11 (2): 113-128.
50. Waldby C.Stem cells, tissue cultures and the production of biovalue.Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine. 2002;6 (3): 305-323.
51. Waldby C,Mitchell RTissue Economies: Blood, Organs and Cell Lines in Late Capitalism. Durham, NC: Duke University Press; 2006:.
52. Watkins N,Dobra S,Bennett P, et al.The management of blood safety in the presence of uncertain risk: A United Kingdom perspective.Transfusion Medicine Reviews. 2011;26 (3): 238-251.
53. World Health Organization (WHO) (1975) Utilization and supply of human blood and blood products. World Health Assembly Resolution, May 1975. Geneva.
54. World Health Organization (WHO) (2004) Global database on blood safety. Report 2001-2002. Available at: http://www.who.int/bloodsafety/GDBS_Report_2001-2002.pdf (accessed January 2006).
55. World Health Organization (WHO) (2005) Global collaboration for blood safety terms of reference. Available at: http://www.who.int/bloodsafety/publications/en/GCBS_termsofref2005.pdf.
56. World Health Organization (WHO) (2007) Blood Services in South-Eastern Europe: Current status and challenges. Available at: http://www.euro.who.int/__data/assets/pdf_file/0014/90401/E90300.pdf.
57. World Health Organization (WHO) (2009) The Melbourne Declaration on 100% voluntary non-remunerated donation of blood and blood components. Available at: http://www.who.int/worldblooddonorday/MelbourneDeclarationWBDD09.pdf.
58. Screening Donated Blood for Transfusion Transmissible Infections: Recommendations. World Health Organization; 2010:.